Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II interim results show improvements in infantile hypophosphatasia with asfotase alfa

April 10, 2014

Genentech presents new MEK inhibitors for cancer

April 9, 2014

Phase I data on LY-2874455 shows safety and a favorable pharmacokinetic profile

April 9, 2014

Two vemurafenib prodrugs developed with improved bioavailability

April 9, 2014

NLRP3 inflammasome inhibitor efficacious in model of ischemia-reperfusion injury

April 9, 2014

Novartis presents results from phase III studies of secukinumab

April 9, 2014

Genentech and Array BioPharma reports ERK-1/2 inhibitor, GDC-0994

April 8, 2014

JNJ-61186372 demonstrates activity for the treatment EGFR/c-Met-aberrant malignancies

April 8, 2014

IGM-55.5 potently binds and kills B cells in NHL patients

April 8, 2014

Lilly and Deciphera Pharmaceuticals present data on LY-3009120

April 8, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...